Bionik Laboratories Corp. company info

CIK 1508381
IRS Number 271340346
State of incorporation DE
Business address 483 BAY STREET
Mail address 483 BAY STREET

Short summary

Bionik Laboratories Corp. is a Ontario, Canada company, with head office located at 483 Bay Street Toronto, Ontario, Canada M5G2C9. In 2019 the company owned a total of 32.11 million USD worth of assets, including 5.38 million USD worth of current assets. The company amassed the most assets last year, totalling up to 32.11 million USD.

Bionik Laboratories Corp. Income Statement

Name [in Millions USD]20092010201120122013201420152016201720182019Trends
Revenue, Net 00.570.99
Cost of Goods and Services Sold 00.390.401.63
Gross Profit 0.01-0.0000.180.581.62
Research and development 0.640.941.541.402.662.833.17
Operating Expenses
Operating Income (Loss) -0.00-0.94-1.45
Interest expense -0.0000.
Other Nonoperating Income (Expense) -6.41-0.070.69-4.86-1.07
Income Tax Expense (Benefit) 000000
Net income -0.00-0.94-1.45-10.101.04-8.07-14.63-9.80

Bionik Laboratories Corp. Balance Sheet

Name [in Millions USD]20092010201120122013201420152016201720182019Trends
Cash and cash equivalents
Accounts Receivable, Net, Current
Deferred income taxes 000
Property, Plant and Equipment, Gross
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment
Goodwill 22.3122.3122.3122.3122.31
Intangible Assets, Net (Excluding Goodwill) 004.944.644.364.22
Total assets
Current assets
Accounts payable
Total current liabilities
Long-term Debt, Excluding Current Maturities 0.50
Total liabilities
Common Stock, Value, Issued
Retained Earnings (Accumulated Deficit) -2.59-8.72-13.97-17.83-36.54-48.48-54.83
Accumulated Other Comprehensive Income (Loss), Net of Tax

Bionik Laboratories Corp. Cash Flow

Name [in Millions USD]20092010201120122013201420152016201720182019Trends
Net income -0.00-0.94-1.45-10.101.04-8.07-14.63-9.80
Depreciation and amortization
Amortization of Intangible Assets 00.550.320.28
Accounts receivable 0000.38-0.191.29
Accounts payable
Deferred revenue
Net Cash Provided by (Used in) Operating Activities -0.00-0.01-0.01-0.01-4.75-6.99-7.71-9.23
Net Cash Provided by (Used in) Investing Activities 000-0.55-0.17-0.02-0.10
Net Cash Provided by (Used in) Investing Activities, Continuing Operations -0.010-0.15-0.55-0.17
Proceeds from Issuance of Common Stock 0.011.390.159.394.550
Net Cash Provided by (Used in) Financing Activities 0.0100.010.014.552.327.709.27
Cash and Cash Equivalents, Period Increase (Decrease) 0.22-0.236.12-0.74-4.84-0.04-0.06